Cite
MLA Citation
N. Umeda et al.. “AB0136 Clinical Aspects and Pathogenicity of Anti-Cyclic Citrullinated Glucose-6-Phospate Isomerase Peptide (CCG) Antibodies in Patients with Rheumatoid Arthritis.” Annals of the rheumatic diseases, vol. 73, 2014, p. 848. http://access.bl.uk/ark:/81055/vdc_100135138864.0x00005c